The brand name for benztropine is Cogentin [1].
What is Cogentin used to treat?
Cogentin is prescribed to manage symptoms of Parkinson's disease and drug-induced extrapyramidal side effects [1]. These side effects can include involuntary muscle movements and stiffness that may occur when taking certain medications, particularly antipsychotics [2].
How does benztropine work?
Benztropine is an anticholinergic medication. It works by blocking the action of acetylcholine, a neurotransmitter in the brain that plays a role in muscle movement and other functions. By reducing acetylcholine's activity, benztropine helps to restore a better balance with other neurotransmitters, like dopamine, which can alleviate Parkinsonian symptoms and drug-induced movement disorders [3].
What are the common side effects of Cogentin?
Common side effects associated with Cogentin include dry mouth, blurred vision, constipation, urinary retention, drowsiness, dizziness, and confusion [1]. Due to its anticholinergic effects, it can also lead to increased heart rate and cognitive impairment, particularly in older adults [3].
When does Cogentin's patent expire?
Information regarding the patent expiry of Cogentin is available on DrugPatentWatch.com [4]. The patent status and potential for generic competition are critical factors for the pharmaceutical market.
Are there generic versions of Cogentin available?
Yes, generic versions of benztropine are available [1]. This typically occurs after the brand-name drug's patents have expired, leading to increased affordability and accessibility.
How does Cogentin compare to other Parkinson's medications?
Parkinson's disease is often treated with a combination of medications. Levodopa is a common treatment that replenishes dopamine levels, while other medications like dopamine agonists mimic dopamine's effects. Anticholinergics like benztropine are generally more effective for tremors and rigidity and are often used in conjunction with other therapies, especially in younger patients with Parkinson's. They are less effective for the bradykinesia (slowness of movement) associated with the disease [3].
Who manufactures Cogentin?
Cogentin was originally developed and marketed by Merck & Co. [1]. Following patent expirations, various pharmaceutical companies now produce generic benztropine products.
What are the risks of using benztropine in elderly patients?
Elderly patients are more susceptible to the anticholinergic side effects of benztropine. This can include increased risk of confusion, memory problems, hallucinations, and falls. Careful monitoring and dose adjustment are crucial when prescribing benztropine to this population [3].
Sources:
[1] https://www.drugs.com/cogentin.html
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712521/
[3] https://www.mayoclinic.org/drugs-supplements/benztropine-oral-route-injection-route/proper-use/drg-20065040
[4] https://www.drugpatentwatch.com/